# Creon After Pancreatic Surgery

> **NCT00535756** · PHASE4 · COMPLETED · sponsor: **Abbott Products** · enrollment: 58 (actual)

## Conditions studied

- Pancreatic Insufficiency

## Interventions

- **DRUG:** Creon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00535756
- **Lead sponsor:** Abbott Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2011-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535756, "Creon After Pancreatic Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00535756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*